Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine and Oral Nitrate in PH
NCT03787082Phase 1Withdrawn
- Start
- Dec 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of sodium nitrate in pulmonary hypertension (PH) and heart failure with preserved ejection fraction (HFpEF) (2 arms). Primary endpoints: Change in Plasma Nitrate at 6 hours and Change in Urine Nitrate at 6 hours. Planned start Dec 2022; status: withdrawn.
02
Drugs
sodium nitrate
03
Conditions
pulmonary hypertension (PH)heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT03787082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03787082.